Key points: Both medications cause similar gastrointestinal side effects, most commonly nausea, diarrhoea, and constipation In the head-to-head trial, liraglutide had double the discontinuation rate of semaglutide (27.6% vs 13.5%) Side effects tend to occur early in treatment and improve over time Wegovy has cardiovascular outcome data (SELECT trial) that liraglutide does not Dosing and practical differences Injection frequency One of the most significant practical differences is how often you inject
Customized Plans Customized Plans Tailored IV Therapy based on your health goals, whether for immunity, energy, or skin health
If you have any more questions about safety, our friendly team is always here to help
Intriguingly, when 5-amino-1MQ treatment was added to the training routine, daily distances run not only increased but tapered off to a much lesser extent than that seen with exercise training alone
The MHRA has approved Ozempic for glycaemic control in adults with type 2 diabetes, though it is not specifically licensed for cardiovascular risk reduction
To better understand the FDAs perspective on GLP-1 compounding, you can read: The FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss The FDAs Policies for Compounders As National GLP-1 Supply Begins To Stabilize The FDAs Guidance on Drug Products That Are Essentially Copies For consistent results and safety, the best GLP-1 for weight loss is an FDA-approved version from a reliable source